pISSN 1226-6051
eISSN 2508-786X

Table. 5.

Table. 5.

Exposure to potential interaction according to each statin

HMG-CoA reductase inhibitors Exposure to potential interaction Total

Yes No
Atorvastatin 471(45%) 568(55%) 1039(100%)
Pravastatin 1(0%) 14(93%) 15(100%)
Simvastatin 7(1%) 0(0%) 7(100%)
Korean J Clin Pharm 2020;30:31-5 https://doi.org/10.24304/kjcp.2020.30.1.31
© 2020 Korean J Clin Pharm